BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 20155614)

  • 1. Beta-carotene and lung cancer in smokers: review of hypotheses and status of research.
    Goralczyk R
    Nutr Cancer; 2009; 61(6):767-74. PubMed ID: 20155614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements.
    Goodman GE; Thornquist MD; Balmes J; Cullen MR; Meyskens FL; Omenn GS; Valanis B; Williams JH
    J Natl Cancer Inst; 2004 Dec; 96(23):1743-50. PubMed ID: 15572756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Source-specific effects of micronutrients in lung cancer prevention.
    Roswall N; Olsen A; Christensen J; Dragsted LO; Overvad K; Tjønneland A
    Lung Cancer; 2010 Mar; 67(3):275-81. PubMed ID: 20004999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reflections on the landmark studies of beta-carotene supplementation.
    Duffield-Lillico AJ; Begg CB
    J Natl Cancer Inst; 2004 Dec; 96(23):1729-31. PubMed ID: 15572749
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands.
    Tanvetyanon T; Bepler G
    Cancer; 2008 Jul; 113(1):150-7. PubMed ID: 18429004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers.
    Omenn GS; Goodman G; Thornquist M; Grizzle J; Rosenstock L; Barnhart S; Balmes J; Cherniack MG; Cullen MR; Glass A
    Cancer Res; 1994 Apr; 54(7 Suppl):2038s-2043s. PubMed ID: 8137335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 6-month daily supplementation with oral beta-carotene in combination or not with benzo[a]pyrene on cell-cycle markers in the lung of ferrets.
    Fuster A; Picó C; Sánchez J; Oliver P; Zingaretti MC; Murano I; Morroni M; Hoeller U; Goralczyk R; Cinti S; Palou A
    J Nutr Biochem; 2008 May; 19(5):295-304. PubMed ID: 17651958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin E supplementation may transiently increase tuberculosis risk in males who smoke heavily and have high dietary vitamin C intake.
    Hemilä H; Kaprio J
    Br J Nutr; 2008 Oct; 100(4):896-902. PubMed ID: 18279551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary and serum alpha-tocopherol, beta-carotene and retinol, and risk for colorectal cancer in male smokers.
    Malila N; Virtamo J; Virtanen M; Pietinen P; Albanes D; Teppo L
    Eur J Clin Nutr; 2002 Jul; 56(7):615-21. PubMed ID: 12080400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro-carcinogenic activity of beta-carotene, a putative systemic photoprotectant.
    Black HS
    Photochem Photobiol Sci; 2004 Aug; 3(8):753-8. PubMed ID: 15295631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-carotene-induced changes in RARbeta isoform mRNA expression patterns do not influence lung adenoma multiplicity in the NNK-initiated A/J mouse model.
    Goralczyk R; Bachmann H; Wertz K; Lenz B; Riss G; Buchwald Hunziker P; Greatrix B; Aebischer CP
    Nutr Cancer; 2006; 54(2):252-62. PubMed ID: 16898870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vitamin intervention on the relationship between GSTM1, smoking, and lung cancer risk among male smokers.
    Woodson K; Stewart C; Barrett M; Bhat NK; Virtamo J; Taylor PR; Albanes D
    Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):965-70. PubMed ID: 10566550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China.
    Yuan JM; Ross RK; Chu XD; Gao YT; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):767-73. PubMed ID: 11440962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial.
    Omenn GS; Goodman GE; Thornquist MD; Balmes J; Cullen MR; Glass A; Keogh JP; Meyskens FL; Valanis B; Williams JH; Barnhart S; Cherniack MG; Brodkin CA; Hammar S
    J Natl Cancer Inst; 1996 Nov; 88(21):1550-9. PubMed ID: 8901853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between participant characteristics and serum concentrations of beta-carotene, retinol, retinyl palmitate, and alpha-tocopherol among participants in the Carotene and Retinol Efficacy Trial (CARET) for prevention of lung cancer.
    Goodman GE; Thornquist M; Kestin M; Metch B; Anderson G; Omenn GS
    Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):815-21. PubMed ID: 8896893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactions of beta-carotene with cigarette smoke oxidants. Identification of carotenoid oxidation products and evaluation of the prooxidant/antioxidant effect.
    Baker DL; Krol ES; Jacobsen N; Liebler DC
    Chem Res Toxicol; 1999 Jun; 12(6):535-43. PubMed ID: 10368317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer associated with beta-carotene supplementation in smokers.
    Prescrire Int; 2010 Jun; 19(107):121. PubMed ID: 20738040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of dietary vitamins E and C fails to ameliorate b-carotene exacerbation of UV carcinogenesis in mice.
    Black HS; Gerguis J
    Nutr Cancer; 2003; 45(1):36-45. PubMed ID: 12791503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Association of beta-carotene with risk of tobacco-related cancers in a cohort of French women.
    Touvier M; Kesse E; Clavel-Chapelon F; Boutron-Ruault MC
    J Natl Cancer Inst; 2005 Sep; 97(18):1338-44. PubMed ID: 16174855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance.
    Albanes D; Heinonen OP; Taylor PR; Virtamo J; Edwards BK; Rautalahti M; Hartman AM; Palmgren J; Freedman LS; Haapakoski J; Barrett MJ; Pietinen P; Malila N; Tala E; Liippo K; Salomaa ER; Tangrea JA; Teppo L; Askin FB; Taskinen E; Erozan Y; Greenwald P; Huttunen JK
    J Natl Cancer Inst; 1996 Nov; 88(21):1560-70. PubMed ID: 8901854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.